Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications.
Hu C, Myers MT, Zhou X, Hou Z, Lozen ML, Nam KH, Zhang Y, Ke A
Mol Cell. 2024 Feb 1;84(3):463-475.e5. doi: 10.1016/j.molcel.2023.12.034. Epub 2024 Jan 18.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 207394 | pSmart-EF1alpha-NlaCas7-p65 | Expresses NlaCas7-p65 activator fusion in mammalian cells |
| 207395 | pSmart-EF1alpha-AcrIC8-NLS | Expresses AcrIC8 with NLS in mammalian cells |
| 207396 | pSmart-EF1alpha-AcrIE2-NLS | Expresses AcrIE2 with NLS in mammalian cells |
| 207397 | pSmart-EF1alpha-AcrIC9-NLS | Expresses AcrIC9 with NLS in mammalian cells |
| 207409 | pET28b-TEV-AcrIC9 | Protein purification vector to produce AcrIC9 in E. coli |
| 207410 | pRSFDuet-3C-AcrIC8 | Protein purification vector to produce AcrIC8 in E. coli |